An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
LENSAR to Present at Two Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
LENSAR, Inc. (NASDAQ: LNSR) has announced that CEO Nick Curtis will present at two upcoming investor conferences. The first, the Piper Sandler 33rd Annual Virtual Healthcare Conference, will feature an on-demand presentation available starting November 22 at 10:00 a.m. ET. The second event, BTIG Ophthalmology Day, will include a fireside chat on November 30 at 8:00 a.m. ET. The Piper Sandler presentation can be accessed on the Company’s website, where it will be available for one month after being posted.
Positive
None.
Negative
None.
ORLANDO, Fla.--(BUSINESS WIRE)--
LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer will present at two upcoming investor conferences:
Piper Sandler 33rd Annual Virtual Healthcare Conference On-demand presentation available beginning Monday, November 22 at 10:00 a.m. Eastern Time
BTIG Ophthalmology Day
Fireside Chat on Tuesday, November 30 at 8:00 a.m. Eastern Time.
The on-demand Piper Sandler presentation can be accessed through the Investors section of the Company's website at https://ir.lensar.com. The webcast will be available for one month after the presentation has been posted. BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative with interest.
About LENSAR
LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.